Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina
Ioannina, 45110, Greece
NCT Number: NCT05658354
The goal of this clinical trial is to investigate the possibility of rehabilitation of mild cognitive deficits in people with metabolic syndrome. We aim to implement a cognitive training program on patients with metabolic syndrome and cognitive deficits, and examine its effectiveness both post-intervention (3 months) and after 12 months.
Researchers will compare two groups, the experimental group that will receive the computerized cognitive training and the control group that will receive no training.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ioannina, 45110, Greece
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
BrainHQ was developed by Posit Science and includes computer-based brain-training exercises organized into six categories: Attention, Brain Speed, Memory, People Skills, Intelligence, and Navigation. Participants were instructed to perform a total of 24 sessions of computerized cognitive training at home, consisting of 45 minutes of training, twice per week, over a 3-month period.
Time frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
MoCA is a screening test for mild cognitive dysfunction; range 0-30, higher scores represent better cognitive function
Time frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Complex Figures assess visuo-constructional ability and visual memory; range 0-36, higher scores represent better cognitive function
Time frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
HVLT-R assesses verbal memory using a list of words; range 0-36 (immediate recall) and range 0-12 (delayed recall), higher scores represent better cognitive function
Time frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Digit Span assesses working memory; range 0-14 (performance) and range 2-9 (span) for forward and backward condition, higher scores represent better cognitive function
Time frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Verbal Fluency assesses executive function that also relies on language component; higher scores represent better cognitive function
Time frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Flanker task assesses executive function and inhibition; range 0-48, higher scores represent better cognitive function
Time frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
CPT assesses executive function and inhibition; range 0-100, higher scores represent better cognitive function
Time frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Set Shifting assesses executive function and set-shifting; range 0-104, higher scores represent better cognitive function
Time frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
N-back assesses working memory; range 0-30, higher scores represent better cognitive function
Time frame: baseline, follow-up (1 year from baseline)
Ecog-II is a measure of everyday functioning that includes 41 items to assess memory, language, visual, spatial and perceptual abilities, planning, organization, and divided attention; higher scores represent worse everyday functioning
University of Ioannina
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT07140445
Cognition Disorders, Glucose Metabolism Disorders
Copenhagen, Capital Region, Denmark
View Trial DetailsNCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT07702669
Glucose Metabolism Disorders, Hyperinsulinism
Harbin, Heilongjiang, China
View Trial Details